Atelvia Sales Down 3.93%, Oppenheimer Reports (WCRX)

Oppenheimer reports that for the week ended March 18, 2011, weekly sales of Atelvia – from Warner Chilcott's WCRX – were $0.5M, down 3.93% week/week. “Atelvia weekly sales are averaging $0.3M during 1Q'11,” Oppenheimer writes. “Weekly NRx of Atelvia were 2,774, down 2.08% week/week. Atelvia NRx market share was up 3 b.p. to 1.9%. Weekly TRx of Atelvia were 3,359, up 0.03% wk/wk. Atelvia TRx market share was up 3 b.p. to 0.7%.” Warner Chilcott closed Monday at $23.25.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsHealth CareOppenheimerPharmaceuticalswarner chilcott
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!